Invitation to presentation of Flerie’s Q2 2025 interim report
24 juli, 08:00
Flerie AB (publ) will publish its interim report for the second quarter of 2025 on Thursday, July 31, at 08:00 CEST. The company will host a live presentation on the same day at 11:00 CEST. The presentation will be led by Ted Fjällman (CEO) and Cecilia Stureborg von Schéele (CFO), held in English, and followed by a Q&A session.
Date and time: Thursday, July 31, at 11:00 CEST.
If you wish to participate via webcast please register via the link below. Please note that it can take a few minutes to receive the confirmation e-mail with the Teams link following registration.
If you have problems with the registration in Teams, please contact: contact@flerie.com.
To ask a question during the Q&A session, please click ‘raise your hand’. Your microphone will be enabled when it’s your turn.
For more information:
Ted Fjällman, CEO
Email: ir@flerie.com
Flerie in brief
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com
Attachments
Invitation to presentation of Flerie’s Q2 2025 interim report
Invitation to presentation of Flerie’s Q2 2025 interim report
24 juli, 08:00
Flerie AB (publ) will publish its interim report for the second quarter of 2025 on Thursday, July 31, at 08:00 CEST. The company will host a live presentation on the same day at 11:00 CEST. The presentation will be led by Ted Fjällman (CEO) and Cecilia Stureborg von Schéele (CFO), held in English, and followed by a Q&A session.
Date and time: Thursday, July 31, at 11:00 CEST.
If you wish to participate via webcast please register via the link below. Please note that it can take a few minutes to receive the confirmation e-mail with the Teams link following registration.
If you have problems with the registration in Teams, please contact: contact@flerie.com.
To ask a question during the Q&A session, please click ‘raise your hand’. Your microphone will be enabled when it’s your turn.
For more information:
Ted Fjällman, CEO
Email: ir@flerie.com
Flerie in brief
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com
Attachments
Invitation to presentation of Flerie’s Q2 2025 interim report
Handelskrig
Apple
Analys
Handelskrig
Apple
Analys
Marknadsöversikt
1 DAG %
Senast
1 mån
Privatekonomi med Placeras expert
Affärsvärlden
